According to new research from the University of Missouri School of Medicine, there may be a way to stave off a type of heart failure by improving the elasticity of cardiac muscles.

Higher baseline serum magnesium levels are linked to a higher risk for cardiac events in HFmrEF/HFpEF, while empagliflozin treatment shows a lower risk for these events in those with higher magnesium.

The American Heart Association (The Association) has awarded a prestigious $160,000 postdoctoral fellowship to Abhishek ...

If someone's in heart failure, that means their heart is no longer able to function well enough to meet their body's needs. According to new research ...

The American Heart Association has awarded a prestigious $160,000 postdoctoral fellowship to Dr. Abhishek Mishra, a ...

Secondary US filings for Bayer assets cannot be relied on again to face future patent cliffs, demanding focus on early-stage ...

Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), ...

Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided updates on the Company's clinical programs and highlighted major milestones for 2026.

The American College of Cardiology issued its inaugural JACC Cardiovascular Statistics report, highlighting the prevalence of ...

The high-risk angioplasty was performed at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, on a patient diagnosed with severe multi-vessel coronary artery disease and a critically low ejection ...

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...